Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058)

NCT02203149 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

399

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir
DRUG: Elbasvir
DRUG: Placebo to Grazoprevir
DRUG: Placebo to Elbasvir

Sponsor

Merck Sharp & Dohme LLC